SCHEMBL2193673

SCHEMBL2193673

O=C(O)c1cncc(Oc2cccnc2)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.58
APP P05067 1/20 0.58
GAA P10253 1/20 0.58
HCAR3 P49019 1/20 0.58
HCAR2 Q8TDS4 1/20 0.58
LMNA P02545 2/20 0.56
TDP1 Q9NUW8 1/20 0.56
GRM5 P41594 4/20 0.54
KMO O15229 1/20 0.51
HTT P42858 2/20 0.49
MEN1 O00255 1/20 0.49
GFER P55789 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
AKR1C3 P42330 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.48
SIRT1 Q96EB6 1/20 0.48
SIRT3 Q9NTG7 1/20 0.48
CYP19A1 P11511 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28765697 0.89 LMNA (0.58) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL1202826 0.88 AKR1C3 (0.62) ALDH1A1HCAR2LMNAHTTMEN1
SCHEMBL1984609 0.87 AKR1C3 (0.67) ALDH1A1APPGAAHCAR3HCAR2
Hydrochloric Acid SCHEMBL6202981 0.86 AKR1C3 (0.65) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL29524445 0.83 SRD5A2 (0.61) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL4318678 0.83 SRD5A2 (0.61) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL28068268 0.81 PARP15 (0.55) ALDH1A1HCAR2LMNAHTTMEN1
SCHEMBL10630750 0.78 ALDH1A1 (0.50) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL1690466 0.78 KMO (0.75) ALDH1A1APPGAAHCAR3HCAR2
SCHEMBL21191037 0.78 ALDH1A1 (0.46) ALDH1A1APPGAAHCAR3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2477629-B1 SUBSTITUTED HETEROARYLAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME UNIV VANDERBILT (US) 2016-08-03 EP disclosed
US-20110172248-A1 SUBSTITUTED HETEROARYLAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME VANDERBILT UNIVERSITY 2011-07-14 US disclosed
US-20110172248-A1 SUBSTITUTED HETEROARYLAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME VANDERBILT UNIVERSITY 2011-07-14 US disclosed
US-20110172248-A1 SUBSTITUTED HETEROARYLAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME VANDERBILT UNIVERSITY 2011-07-14 US disclosed
WO-2011035186-A1 SUBSTITUTED HETEROARYLAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME VANDERBILT UNIVERSITY (US) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172248-A1 SUBSTITUTED HETEROARYLAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME GRM5, GRIK5, GRM2 ALDH1A1 4706/4885APP 2278/4885GAA 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.